Sun Pharmaceutical Industries Ltd's share price has fallen by -0.19%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,691.30, and market participants are assessing the implications. The stock has a PE ratio of 37.3900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.






